Status:
COMPLETED
Angiomatoid Fibrous Histiocytoma: a Single Institution Case-series
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Angiomatoid Fibrous Histiocytoma
Eligibility:
All Genders
Brief Summary
single institution cases series review of histological and clinical data
Detailed Description
single institution cases series review of histological and clinical data Investigators will retrieve from the archives of the Rizzoli Institute all the cases with a histological diagnosis of Angiomato...
Eligibility Criteria
Inclusion
- Male and female patients treated at Rizzoli Institute from 01 January 2006 to 31 December 2017
- Diagnosis of Angiomatoid Fibrous Histiocytoma
- Histological slides/formalin-fixed paraffin-embedded tissue tumor (FFPE) blocks from archive available to perform the histology analysis
- Written informed consent prior to any study-specific analysis and/or data collection
Exclusion
- • Patients with histological diagnosis different from Angiomatoid Fibrous Histiocytoma
Key Trial Info
Start Date :
November 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 25 2019
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT03759327
Start Date
November 30 2018
End Date
May 25 2019
Last Update
February 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCC Rizzoli Orthopedic Institute
Bologna, Italy, 40136